Dapagliflozin does not impair microvascular hemorheology in type 2 diabetes mellitus: A multicenter randomized controlled trial (D-PATH study) [0.03%]
达格列净不影响2型糖尿病微血管血液流变学：一项多中心随机对照试验（D-PATH研究）
Yuki Nakatani,Nobuyuki Banba,Shoya Ono et al.
Yuki Nakatani et al.
Aims: Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular and renal events beyond glucose lowering, but their hematocrit-raising effects raise concerns about increased blood viscosity and microvascular impairm...
Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital-based claims database [0.03%]
日本医院索赔数据库中自身免疫性炎症性疾病合并2型糖尿病患者使用钠-葡萄糖协同转运蛋白2抑制剂治疗的尿路感染风险：靶向试验模拟研究
Hiroshi Tsushima,Nobuyuki Yajima,Takashi Nomiyama et al.
Hiroshi Tsushima et al.
Aims/introduction: To evaluate whether sodium-glucose cotransporter 2 inhibitor (SGLT2i) initiation is associated with the risk of urinary tract infection (UTI), with upper UTI and genital infection assessed as secondary ...
Taiwanese consensus statement on the use of diabetes-specific formula: Scientific evidence [0.03%]
台湾糖尿病特定配方食证据的共识声明
Chih-Hsun Chu,Hui-Yu Peng,Chun-Chuan Lee et al.
Chih-Hsun Chu et al.
Introduction: Medical Nutrition Therapy remains the cornerstone of diabetes management. Clinical evidence shows that early intervention with medical nutrition therapy can significantly improve cardiometabolic markers, the...
Primary cardiovascular preventive effect of thiazolidinedione in adults with type 2 diabetes: A nationwide cohort study in Korea [0.03%]
韩国成人2型糖尿病患者噻唑烷二酮的主要心血管预防作用：一项全国队列研究
Yun Young Choi,Jimin Jeon,Minyoul Baik et al.
Yun Young Choi et al.
Background: Thiazolidinediones (TZDs) are antidiabetic agents recognized for their effectiveness in secondary cardiovascular prevention; however, their role in primary prevention remains uncertain. This study evaluated th...
Cholesterol accumulation in monocytes is associated with the severity of diabetic complications and the efficacy of glycemic control interventions in patients with type 2 diabetes [0.03%]
胆固醇在单核细胞中的堆积与2型糖尿病患者并发症的严重程度及血糖控制干预的有效性相关
Hideyuki Okuma,Takahiro Tsutsumi,Asako Miyazaki et al.
Hideyuki Okuma et al.
Aims/introduction: Monocyte dysfunction is central to the pathogenesis of diabetes. This study investigated the association between cholesterol accumulation in monocytes and diabetic complications as well as post-discharg...
Letter to the editor: Association between thyroid dysfunction and cognitive impairment in type 2 diabetes mellitus: A cross-sectional study [0.03%]
论著致编者信：2型糖尿病患者甲状腺功能异常与认知障碍的关联性分析：横断面研究
Aysha Khalid,Meva Ram,Romaisa Khalid
Aysha Khalid
Continuous glucose monitoring-guided management of capivasertib-associated hyperglycemia: A case series of three patients [0.03%]
连续血糖监测指导卡培西替引起的高血糖症管理：3例报告
Hiroki Okumura,Ryotaro Bouchi,Kenju Ando et al.
Hiroki Okumura et al.
Capivasertib, an AKT inhibitor for advanced breast cancer, frequently induces hyperglycemia. We present a case series of three patients (two without pre-existing diabetes) monitored with continuous glucose monitoring. Hyperglycemia develope...
Case Reports
Journal of diabetes investigation. 2026 May 19. DOI:10.1111/jdi.70342 2026
Elevated serum galectin-3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10-year follow-up study [0.03%]
血清galectin-3水平升高可预测日本普通人群II型糖尿病的发病率：一项为期十年的随访研究
Harumi Takubo-Yoshimura,Mika Enomoto,Ako Fukami et al.
Harumi Takubo-Yoshimura et al.
Aims/introduction: Although several studies have reported elevated serum galectin-3 levels in type 2 diabetes mellitus, its association with type 2 diabetes mellitus, in Japan, where obesity is relatively uncommon, remain...
Assessment of triglyceride-glucose composite indices associated mortality risk in diabetes-related heart failure [0.03%]
糖尿病相关心力衰竭的甘油三酯-葡萄糖联合指标与死亡风险评估研究
Qijie Zhao,Xiao Cai,Xing Wang et al.
Qijie Zhao et al.
Background: Patients with diabetes are at an increased risk of heart failure. The triglyceride-glucose index increases the risk of diabetes-related heart failure (dHF). We aimed to validate a practical clinical risk score...